Navigation Links
Mom's HIV Drugs May Pass to Baby in Womb, Breast-Feeding
Date:7/22/2012

SATURDAY, July 21 (HealthDay News) -- Babies born to HIV-positive women taking antiretroviral drugs to fight the disease may become exposed to the drugs in the womb and during breast-feeding, new research shows.

Hair and blood samples taken from the 3-month-old infants of women with HIV found evidence that two medications pass from mother to baby in the womb, while a third medication is passed both in utero and by breast milk.

The study by researchers from the University of California, San Francisco and Makerere University in Uganda included more than 100 HIV-positive mothers who were breast-feeding their infants and taking either lopinavir and ritonavir, or efavirenz.

HIV-positive women take antiretroviral drugs to help prevent them from spreading HIV to their fetus, but HIV-positive women are told not to breast-feed because HIV can be transmitted through breast milk, experts say. But in some developing nations, formula-feeding isn't an option.

The researchers analyzed hair and blood samples taken from the HIV-positive women and their 3-month-old HIV-negative infants.

Blood tests detect recent exposure to a drug, while hair samples show exposure over the course of a month. By sampling both the blood and hair of the infants, researchers said they were able to determine when the drugs were passed from the women to their babies.

"Since fetuses start growing hair in the womb, hair sampling gives us an opportunity to examine exposures to drug before birth," senior study author Dr. Monica Gandhi, associate professor of medicine at the UCSF Division of HIV/AIDS at San Francisco General Hospital and Trauma Center, said in a university news release.

The infants' hair samples revealed they had significant exposure to the antiretroviral drugs.

Based on the level of drug in the hair and in the blood, the researchers concluded that lopinavir and ritonavir exposure occurs in the womb but not during breast-feeding. Efavirenz appears to be transmitted in utero and during breast-feeding.

The findings could lead to the development of new ways to protect infants from HIV transmission and shed light on toxicities and resistance to anti-HIV drugs, the study authors noted.

"Our findings, as we verify them, will have important implications. One, being able to measure drug exposures of fetuses in the womb and during breast-feeding can help us understand how to better protect infants from HIV transmission from HIV-positive mothers during pregnancy, birth and after birth," said Gandhi. "Second, the development of resistance to antiretroviral medications in infants is an important issue," she added.

After low levels of exposure, HIV can develop resistance to the class of medications to which efavirenz belongs, she explained.

The study was expected to be presented on Saturday at the 4th International Workshop on HIV Pediatrics in Washington, D.C., ahead of a presentation at the 19th International AIDS Conference. The data and conclusions of research presented at medical meetings should be viewed as preliminary until published in a peer-reviewed journal.

More information

The U.S. Centers for Disease Control and Prevention has more about mother-to-child HIV Transmission and Prevention.

-- Mary Elizabeth Dallas

SOURCE: University of California, San Francisco, news release, July 21, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Rutgers study: Anxiety disorders in poor moms likely to result from poverty, not mental illness
2. H1N1 Flu Vaccine Safe for Expectant Moms, Offspring: Study
3. Frumpy and Frustrated Moms Can Now Get Free Help Losing Weight
4. Canadian teen moms run higher risk of abuse, depression than older mothers
5. Overweight Moms More Apt to Have Large Babies, Study Says
6. Depressed Moms May Hinder Babies Sleep
7. Depressed moms behavior may play role in infants sleep problems
8. New pregnancy risk for babies and moms
9. Children Born to Obese Moms May Face Higher Autism Risk: Study
10. Benefits of HIV drugs rise -- but less than previously believed, Penn study shows
11. Hair samples from infants show exposure to anti-HIV drugs in the womb and during breast-feeding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... FALLS CHURCH, Va. (PRWEB) , ... February 23, 2017 , ... ... , worries, or problems. He has also continued to spiritually evolve, which is the ... his published book “ Our Spiritual Truths ” (published by Balboa Press) attempts to ...
(Date:2/22/2017)... ... February 22, 2017 , ... Gevir, a New Zealand-based company that focuses on ... are coming soon to Amazon.com, the world’s largest online retailer. , The ... develop an effective natural treatment for Shelley’s Multiple Sclerosis, which she’d been diagnosed with ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... secure messaging services to the largest network of hospitals, health information exchanges, ... National Coordinator for Health Information Technology (ONC-HIT) 2015 Edition Health IT Module Certification ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... leads to fewer trips the emergency room, fewer hospital admissions, and better blood ... of Managed Care® (AJMC®) finds. The study can be found here . ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... just as effective on smaller and sometimes harder to reach ones, according to ... presented at the International Stroke Conference in Houston by Ricardo A. Hanel, MD, ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 22, 2017 Orthopedic and cardiac devices ... aging demographic patterns lead to an increasing prevalence ... and exercise-related injuries, chronic back problems, heart valve ... gains. The future of medical implants faces many ... questions and more: - What types of ...
(Date:2/23/2017)... 23, 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ ... report its fourth quarter and full year 2016 financial ... the U.S. financial markets. Following the announcement, members of ... to discuss the results and provide a general corporate ... event can be obtained as follows: Thursday, ...
(Date:2/22/2017)... Calif. , Feb. 22, 2017 IRIDEX ... it will release financial results for the fourth quarter ... March 8, 2017.  The Company,s management team will host ... / 5:00 p.m. ET. Investors interested in ... dialing (844) 707-0665 for domestic callers or (703) 326-3030 ...
Breaking Medicine Technology: